Femke Ehlers

Femke Ehlers currently serves as a Scientist in Oncology at Numab Therapeutics AG, a position held since May 2023. Previously, Femke Ehlers worked as a Scientist in Transfers and Operations at Veracyte, Inc. from February 2022 to February 2023. Femke Ehlers completed a PhD at Maastricht University, focusing on donor-derived NK cell therapy for hematological and solid cancers, with the dissertation defended in February 2023. Additional research experience includes a Research Fellow position at Oregon Health & Science University, and internships at Karolinska Institutet, Maastricht University, Christian-Albrechts-Universität zu Kiel, and The Ohio State University. Femke Ehlers holds a Master of Science in Biomedical Science from Maastricht University and a Bachelor’s degree in Biology from Kiel University.